On Wednesday, Oct. 10 at 11:00 am, the U.S. Food and Drug Administration will host a conference call for clinicians concerning the Multistate Meningitis Outbreak Investigation.
The Centers for Disease Control and Prevention and the Food and Drug Administration continue to work closely with state public health departments on a multistate investigation of fungal meningitis among patients who received an epidural steroid injection. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center, located in Framingham, Mass. During this COCA Call, CDC subject matter experts will review current epidemiology of the outbreak, describe clinical presentation and features of fungal meningitis, and review CDC’s recommended treatment guidance.
Multistate Meningitis Outbreak Investigation: Information and Guidance for Clinicians
Date: Wednesday, October 10, 2012 - TODAY
Time: 11:00 am - 12:00 pm (Pacific)
Join by Phone:
Dial-In Number: 888-790-6180
Passcode: COCA
Presenters:
Melissa K. Schaefer, MD
Medical Officer
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease and Control and Prevention
Tom Chiller, MD, MPH
Medical Epidemiologist
Division of Foodborne, Waterborne & Environmental Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease and Control and Prevention
This is an audio only call. There are no slides or handouts for this call. The recorded call audio and transcript will be available a few days after the live call. To view the record call materials please visit the call webpage at http://emergency.cdc.gov/coca/calls/2012/callinfo_101012.asp
Thank you for your support of FDA and its mission.